Please login to the form below

Not currently logged in
Email:
Password:

Novo Nordisk hires new global CMO

Novo Nordisk has hired Dr Alan C Moses as vice-president and global Chief Medical Officer

Danish pharmaceutical company Novo Nordisk has hired Dr Alan C Moses as vice-president and global Chief Medical Officer (CMO).

Moses is currently CMO of Novo Nordisk's US affiliate, Novo Nordisk Inc.

In the newly expanded role, Moses will work closely with senior colleagues in Denmark to serve as the principle voice of clinical science for the company worldwide, providing clinical and medical affairs expertise.

Moses was formerly senior vice-president and CMO at the Joslin Diabetes Center and joined Novo Nordisk in April 2004 as associate vice-president of medical affairs and since then has also assumed responsibility for clinical research in diabetes.

Prior to joining Novo Nordisk, Moses spent 23 years at Harvard Medical School-affiliated institutions where he rose to the rank of Professor of Medicine. He has written more than 100 peer- reviewed articles on the treatment of diabetes and has been recognised internationally for his research in diabetes and growth factors.

Mads Krogsgaard Thomsen, executive vice-president and chief science officer (CSO) for Novo Nordisk, said: "The broadening of Novo Nordisk's diabetes therapeutic portfolio with the development of liraglutide and other novel molecules in the pipeline, and the increasing importance of the US to the business, requires a leader with clinical and research expertise to assume the role of CMO."

9th January 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics